SCHEMBL7535852

SCHEMBL7535852

c1cc(NCC2CO2)ccc1Cc1ccc(NCC2CO2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MGLL Q99685 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
CHRM2 P08172 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM3 P20309 1/20 0.35
HPGD P15428 2/20 0.34
HTT P42858 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GLA P06280 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8981580 0.89 SMN1; SMN2 (0.42) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL19901829 0.87 LTA4H (0.33) LMNAMEN1KMT2AMGLLSMN1; SMN2
SCHEMBL11174017 0.86 KMT2A (0.33) LMNAMEN1KMT2AMGLLSMN1; SMN2
Water SCHEMBL44003 0.85 NPC1 (0.35) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL19901809 0.84 KCNH3 (0.36) MEN1KMT2AMGLL
SCHEMBL21401818 0.83 SMN1; SMN2 (0.39) LMNASMN1; SMN2NPC1RAB9AHTT
SCHEMBL18615654 0.83 ALDH1A1 (0.36) MEN1KMT2ASMN1; SMN2CHRM2CHRM5
SCHEMBL7776111 0.80 KMT2A (0.40) LMNAMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL4271408 0.80 L3MBTL1 (0.41) LMNAMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL11702489 0.80 RAB9A (0.37) LMNAMEN1KMT2ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6482530-B2 COMPRISING POLYOLEFINS HAVING GIVEN MELT FLOW RATE AND/OR OLEFIN POLYMERS HAVING AT LEAST ONE FUNCTIONAL GROUP CAPABLE OF REACTING WITH AN EPOXY GROUP; AND AN EPOXY COMPOUND SUCH AS EPOXIDIZED SOYBEAN OIL HAVING AT LEAST 2 EPOXY GROUPS SHOWA DENKO K.K. (JP) 2002-11-19 US claimed
US-6201066-B1 EXTRUSION LAMINATION TO SUBSTRATES WITH GROUP REACTIVE WITH EPOXY GROUP AND POLYOLEFINS SHOWA DENKO K.K. (JP) 2001-03-13 US claimed
US-6099685-A FOOD PACKAGING, IT REACTS WITH THE EPOXY COMPOUND IN THE PROCESS OF OXIDATION, EPOXY COMPOUND IS FIRST GRAFTED TO THE POLYETHYLENE AND THEN THE UNREACTED EPOXY GROUPS REACT WITH THE FUNCTIONAL GROUPS (E.G., AMINO GROUPS, CARBOXYL GROUPS, SHOWA DENKO K.K. (JP) 2000-08-08 US claimed
EP-0526072-B1 Thermosensitive recording material NEW OJI PAPER CO LTD (JP) 1995-09-13 EP claimed
US-5246906-A Sulfonyl-urea or -thiourea color developer, oil and plasticizer resistant, storage stable OJI PAPER CO., LTD. (JP) 1993-09-21 US claimed
EP-0526072-A1 Thermosensitive recording material NEW OJI PAPER CO., LTD. (JP) 1993-02-03 EP claimed
EP-0503856-A1 Thermosensitive recording material OJI PAPER COMPANY LIMITED (JP) 1992-09-16 EP claimed
US-10597412-B2 Epoxy compound, mixture, composition, and cured product comprising same, method for preparing same, and use thereof KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2020-03-24 US disclosed
US-9902803-B2 Epoxy compound having alkoxy silyl group, composition comprising same, cured product, use thereof and method for preparing epoxy compound having alkoxy silyl group KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2018-02-27 US disclosed
US-9902803-B2 Epoxy compound having alkoxy silyl group, composition comprising same, cured product, use thereof and method for preparing epoxy compound having alkoxy silyl group KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2018-02-27 US disclosed
US-9645494-B2 Resist underlayer film forming composition containing low molecular weight dissolution accelerator NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-05-09 US disclosed
US-20170066789-A1 NOVEL EPOXY COMPOUND, MIXTURE, COMPOSITION, AND CURED PRODUCT COMPRISING SAME, METHOD FOR PREPARING SAME, AND USE THEREOF KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2017-03-09 US disclosed
US-20170066789-A1 NOVEL EPOXY COMPOUND, MIXTURE, COMPOSITION, AND CURED PRODUCT COMPRISING SAME, METHOD FOR PREPARING SAME, AND USE THEREOF KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2017-03-09 US disclosed
EP-0336391-B1 Reversibly color-changeable materials TEIJIN LTD (JP) 1994-01-26 EP disclosed
EP-0503856-A1 Thermosensitive recording material OJI PAPER COMPANY LIMITED (JP) 1992-09-16 EP disclosed
US-5068062-A Crosslinked resin containing 4,4*-diaminodiphenylmethane units with the amine quaternized and an electrolytic material TEIJIN LIMITED (JP) 1991-11-26 US disclosed
EP-0172685-B1 CURING AGENT FOR THERMOSETTING RESIN PAINTS KANSAI PAINT CO., LTD. (JP) 1990-05-23 EP disclosed
EP-0336391-A2 Reversibly color-changeable materials TEIJIN LIMITED (JP) 1989-10-11 EP disclosed
US-4720569-A Curing agent for thermosetting resin paints KANSAI PAINT CO., LTD. (JP) 1988-01-19 US disclosed
EP-0172685-A2 Curing agent for thermosetting resin paints KANSAI PAINT CO., LTD. (JP) 1986-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170066789-A1 NOVEL EPOXY COMPOUND, MIXTURE, COMPOSITION, AND CURED PRODUCT COMPRISING SAME, METHOD FOR PREPARING SAME, AND USE THEREOF ESD, NOTUM, PFAS LMNA 1447/4885MEN1 3493/4885KMT2A 583/4885
US-10597412-B2 Epoxy compound, mixture, composition, and cured product comprising same, method for preparing same, and use thereof ESD, NOTUM, GMNN LMNA 1113/4885MEN1 2851/4885KMT2A 477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.